Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of the immune response induced by pertussis OMVs-based vaccine.
Bottero D, Gaillard ME, Zurita E, Moreno G, Martinez DS, Bartel E, Bravo S, Carriquiriborde F, Errea A, Castuma C, Rumbo M, Hozbor D. Bottero D, et al. Among authors: zurita e. Vaccine. 2016 Jun 14;34(28):3303-9. doi: 10.1016/j.vaccine.2016.04.079. Epub 2016 May 3. Vaccine. 2016. PMID: 27151884
Pertussis epidemiology in Argentina: trends over 2004-2007.
Hozbor D, Mooi F, Flores D, Weltman G, Bottero D, Fossati S, Lara C, Gaillard ME, Pianciola L, Zurita E, Fioriti A, Archuby D, Galas M, Binsztein N, Regueira M, Castuma C, Fingermann M, Graieb A. Hozbor D, et al. Among authors: zurita e. J Infect. 2009 Oct;59(4):225-31. doi: 10.1016/j.jinf.2009.07.014. Epub 2009 Aug 3. J Infect. 2009. PMID: 19651156 Review.
Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.
Ambrosis N, Martin Aispuro P, Belhart K, Bottero D, Crisp RL, Dansey MV, Gabrielli M, Filevich O, Genoud V, Giordano A, Lin MC, Lodeiro A, Marceca F, Pregi N, Lenicov FR, Rocha-Viegas L, Rudi E, Solovey G, Zurita E, Pecci A, Etchenique R, Hozbor D. Ambrosis N, et al. Among authors: zurita e. Front Med (Lausanne). 2021 Feb 4;8:640688. doi: 10.3389/fmed.2021.640688. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33614689 Free PMC article.
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Rudi E, et al. Among authors: zurita e. Front Immunol. 2022 Sep 29;13:1020159. doi: 10.3389/fimmu.2022.1020159. eCollection 2022. Front Immunol. 2022. PMID: 36248791 Free PMC article.
Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.
Bottero D, Rudi E, Martin Aispuro P, Zurita E, Gaillard E, Gonzalez Lopez Ledesma MM, Malito J, Stuible M, Ambrosis N, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D. Bottero D, et al. Among authors: zurita e. Front Immunol. 2023 Nov 10;14:1271209. doi: 10.3389/fimmu.2023.1271209. eCollection 2023. Front Immunol. 2023. PMID: 38022542 Free PMC article.
27 results